DK3728287T3 - Proteinoprensning og virusinaktivering med alkylglycosider - Google Patents

Proteinoprensning og virusinaktivering med alkylglycosider Download PDF

Info

Publication number
DK3728287T3
DK3728287T3 DK18826000.4T DK18826000T DK3728287T3 DK 3728287 T3 DK3728287 T3 DK 3728287T3 DK 18826000 T DK18826000 T DK 18826000T DK 3728287 T3 DK3728287 T3 DK 3728287T3
Authority
DK
Denmark
Prior art keywords
protein purification
virus inactivation
alkyl glycosides
glycosides
alkyl
Prior art date
Application number
DK18826000.4T
Other languages
English (en)
Inventor
Tobias Brandt
Hubert Metzner
Carsten Horn
Thomas Nowak
Original Assignee
CSL Behring Lengnau AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CSL Behring Lengnau AG filed Critical CSL Behring Lengnau AG
Application granted granted Critical
Publication of DK3728287T3 publication Critical patent/DK3728287T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18Liquid substances or solutions comprising solids or dissolved gases
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/20Targets to be treated
    • A61L2202/21Pharmaceuticals, e.g. medicaments, artificial body parts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK18826000.4T 2017-12-19 2018-12-19 Proteinoprensning og virusinaktivering med alkylglycosider DK3728287T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17208630 2017-12-19
PCT/EP2018/085735 WO2019121846A1 (en) 2017-12-19 2018-12-19 Protein purification and virus inactivation with alkyl glycosides

Publications (1)

Publication Number Publication Date
DK3728287T3 true DK3728287T3 (da) 2024-06-10

Family

ID=60888188

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18826000.4T DK3728287T3 (da) 2017-12-19 2018-12-19 Proteinoprensning og virusinaktivering med alkylglycosider

Country Status (11)

Country Link
US (1) US11479578B2 (da)
EP (2) EP4368210A2 (da)
JP (1) JP7458980B2 (da)
KR (1) KR20200100771A (da)
CN (1) CN111511756B (da)
AU (1) AU2018390797A1 (da)
BR (1) BR112020010760A2 (da)
CA (1) CA3085885A1 (da)
DK (1) DK3728287T3 (da)
SG (1) SG11202004725PA (da)
WO (1) WO2019121846A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020401034A1 (en) 2019-12-12 2022-06-30 Eli Lilly And Company Methods for viral inactivation by environmentally compatible detergents
CN111110876A (zh) * 2020-01-20 2020-05-08 华兰生物工程重庆有限公司 一种特异性人免疫球蛋白病毒灭活工艺
BR112023018268A2 (pt) * 2021-03-09 2023-10-31 Japan Chem Res Método para produzir uma proteína de fusão
WO2023115027A2 (en) * 2021-12-16 2023-06-22 Bristol-Myers Squibb Company Detergent for viral inactivation
TW202403043A (zh) 2022-03-18 2024-01-16 美商健臻公司 重組人類酸性鞘磷脂酶醫藥組合物及方法
CN117866038B (zh) * 2024-03-11 2024-05-28 北京百力格生物科技有限公司 纯化含有宿主核酸的带亲和标签的酸性蛋白的方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5759855A (en) 1988-09-14 1998-06-02 La Jolla Cancer Research Foundation Methods for modifying the binding activity of cell adhesion receptors
EP0531639B1 (en) * 1991-07-18 1999-09-01 F. Hoffmann-La Roche Ag Tocopherol cyclase
DE19528221C2 (de) 1995-08-01 1998-10-22 Blutspendedienst Der Drk Lande Verfahren zur Herstellung eines virussicheren, therapeutischen Präparates aus Humanplasma
WO1997027873A1 (en) 1996-01-30 1997-08-07 Brigham & Women's Hospital, Inc. Antibodies for modulating cd47-mediated neutrophil transmigration
AU3514997A (en) 1996-07-12 1998-02-09 Schering Corporation Mammalian tnf-alpha convertases
AU2008200700C1 (en) * 1997-04-15 2013-04-04 Daiichi Sankyo Co., Ltd Novel Protein and Process for Producing The Same
SE9904803D0 (sv) 1999-12-27 1999-12-27 Amersham Pharm Biotech Ab Method for the isolation of hydrophobic proteins
ATE494909T1 (de) * 2002-11-20 2011-01-15 Bestewil Holding Bv Zusammensetzungen mit antigen-komplexen,verfahren zu ihrer herstellung und verfahren zur verwendung derantigen-komplexe zur vakzinierung
US20100216161A1 (en) 2009-02-26 2010-08-26 Vertex Pharmaceuticals Incorporated Method for identifying protease inhibitors
AU2015252110A1 (en) * 2009-12-18 2015-11-26 Csl Limited Method of purifying polypeptides
AU2010202125B1 (en) * 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
AU2015204304B2 (en) 2010-12-15 2016-04-07 Takeda Pharmaceutical Company Limited Viral Inactivation Using Improved Solvent-Detergent Method
RU2565827C2 (ru) 2011-07-20 2015-10-20 Эбботт Байолоджикалз Б.В. Способ получения вирусного антигена и вакцин
CN103214566A (zh) * 2013-03-30 2013-07-24 福州新北生化工业有限公司 一种g因子的分离纯化方法
CN105722523B (zh) 2013-11-15 2022-06-14 豪夫迈·罗氏有限公司 使用环保洗涤剂的病毒灭活方法
JP6573989B2 (ja) 2015-05-22 2019-09-11 ツェー・エス・エル・ベーリング・レングナウ・アクチエンゲゼルシャフト 血友病を処置するための切断型フォン・ヴィルブランド因子ポリペプチド
GB2581882B (en) 2017-08-01 2023-03-29 Ankasa Regenerative Therapeutics Inc WNT compositions and methods of process from serum-free culturing conditions

Also Published As

Publication number Publication date
EP3728287A1 (en) 2020-10-28
US11479578B2 (en) 2022-10-25
AU2018390797A1 (en) 2020-07-02
JP2021506875A (ja) 2021-02-22
EP3728287B1 (en) 2024-04-10
EP4368210A2 (en) 2024-05-15
CN111511756A (zh) 2020-08-07
WO2019121846A1 (en) 2019-06-27
CN111511756B (zh) 2023-11-03
BR112020010760A2 (pt) 2020-11-17
CA3085885A1 (en) 2019-06-27
US20200317727A1 (en) 2020-10-08
SG11202004725PA (en) 2020-07-29
KR20200100771A (ko) 2020-08-26
JP7458980B2 (ja) 2024-04-01

Similar Documents

Publication Publication Date Title
DK3728287T3 (da) Proteinoprensning og virusinaktivering med alkylglycosider
DK3472183T3 (da) Variant adeno-associerede virus og fremgangsmåder til anvendelse
DK3445773T3 (da) Adeno-associerede virusvariantcapsider og fremgangsmåder til anvendelse deraf
DK3872085T3 (da) Stam-virussekvenser og anvendelser heraf
DK3283106T3 (da) Terapeutiske antistoffer og anvendelser deraf
DK3368655T3 (da) Forbedret proteinekspression og fremgangsmåder dertil
DK3160476T3 (da) Substituerede nukleosider, nukleotider og analoger dertil til anvendelse til behandling af virusinfektioner
DK3610005T3 (da) Peptidligase og anvendelse deraf
DK3043865T3 (da) Fremgangsmåder og farmaceutiske sammensætningr til behandlingen af hepatitis b-virusinfektion
DK3099800T3 (da) Ekspression og oprensning af crm197 og beslægtede proteiner
DK3498292T3 (da) Uspa2-proteinkonstruktioner og anvendelser deraf
DK3346056T3 (da) Rengøringssystem og fremgangsmåde
DK3687513T3 (da) Behandling af fragilt x-syndrom og autisme med cannabidiol
DK3562946T3 (da) Oncolytiske virusser og terapeutiske molekyler
DK3294740T3 (da) Hidtil ukendte sulfonimidoylpurinonforbindelser og derivater til behandling og profylakse af virusinfektion
DK3390325T3 (da) Gødning omfattende bakterier og protozoer
DK3100050T3 (da) Immobiliserede proteiner og anvendelse deraf
DK3416974T3 (da) Proteinoprensning
DK3316951T3 (da) Eyewear and flexible elements
DK3200748T3 (da) Sammensætninger og fremgangsmåder til behandling og profylakse af infektioner på operationssted
DK3448419T3 (da) Interferon-beta-antistoffer og anvendelser deraf
HK1253557A1 (zh) 純化和/或病毒滅活的方法
DK3630143T3 (da) Onkolytisk virus og fremgangsmåde
DK3722291T3 (da) Indolinonforbindelser og deres anvendelse i behandlingen af fibrotiske sygdomme
DK3532059T3 (da) Kombinationsterapi med bromdomæne- og ekstraterminal proteinhæmmer